Publications by authors named "Thomas Lion"

Claim this Profile
S
Scaled-up non-thermal plasma-generating device Plasmatico enables effective and harmless disinfection of personal protective equipment.
Eva Vaňková, Klára Obrová, Jan Hodek, Anna Machková, Petra Kašparová, Thomas Lion

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of children and adolescents with chronic myeloid leukemia in chronic phase: International pediatric chronic myeloid leukemia expert panel recommendations.
Frédéric Millot, Mirella Ampatzidou, Nirmalya Roy Moulik, Sanjay Tewari, Alaa Elhaddad, Thomas Lion

Leukemia· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Recent Translational and Therapeutic Developments on Clinical Course of BCR::ABL1-Positive and -Negative Myeloproliferative Neoplasms.
Tariq I Mughal, John Mascarenhas, Raajit K Rampal, Prithviraj Bose, Thomas Lion

Hematol Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR-T cells for the treatment of pediatric chronic myeloid leukemia in repeatedly relapsed lymphoid blast phase.
Laura-Jane Kramp, Christiane Heydrich-Karsten, Stephanie Sembill, Axel Karow, Thomas Lion

Ann Hematol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated multi-omics identifies pathways governing interspecies interaction between A. fumigatus and K. pneumoniae.
Tamires Bitencourt, Filomena Nogueira, Sabrina Jenull, Trinh Phan-Canh, Michael Tscherner, Thomas Lion

Commun Biol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination cell therapy leads to clonal deletion of donor-specific T cells in kidney transplant recipients.
Ana F David, Andreas Heinzel, Michael Kammer, Constantin Aschauer, Roman Reindl-Schwaighofer, Thomas Lion

EBioMedicine· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of fungal DNAemia mediated by putatively non-pathogenic fungi in immunocompromised patients with febrile neutropenia: a prospective cohort study.
Chantal Lucini, Klára Obrová, Isabella Krickl, Filomena Nogueira, Iva Kocmanová, Thomas Lion

J Hematol Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective use of molecular minimal residual disease for risk stratification in children and adolescents with acute lymphoblastic leukemia : Long-term results of the AIEOP-BFM ALL 2000 trial in Austria.
Leila Ronceray, Michael Dworzak, Karin Dieckmann, Georg Ebetsberger-Dachs, Evgenia Glogova, Thomas Lion

Wien Klin Wochenschr· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative transcriptomics coupled to developmental grading via transgenic zebrafish reporter strains identifies conserved features in neutrophil maturation.
Stefanie Kirchberger, Mohamed R Shoeb, Daria Lazic, Andrea Wenninger-Weinzierl, Kristin Fischer, Thomas Lion

Nat Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combinatorial treatment options for highly resistant compound mutations in the kinase domain of the BCR::ABL1 fusion gene in Ph-positive leukemias.
Isabella Sponseiler, Anna-Maria Bandian, Petra Pusic, Thomas Lion

Am J Hematol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vienna Cancer Stem Cell Club (VCSCC): 20 year jubilee and future perspectives.
Peter Valent, Irina Sadovnik, Barbara Peter, Daniel Ivanov, Axel Schulenburg, Thomas Lion

Expert Rev Hematol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS.
Karin Bauer, Sigrid Machherndl-Spandl, Lukas Kazianka, Irina Sadovnik, Sinan Gültekin, Thomas Lion

Leukemia· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proline catabolism is a key factor facilitating Candida albicans pathogenicity.
Fitz Gerald S Silao, Tong Jiang, Biborka Bereczky-Veress, Andreas Kühbacher, Kicki Ryman, Thomas Lion

PLoS Pathog· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of viable SARS-CoV-2 on the hands of hospitalized children with COVID-19.
Meryl Haas, Paola Fürhacker, Jan Hodek, Petra Stangl, Isabelle Alon, Thomas Lion

Clin Microbiol Infect· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silver nanoparticles with plasma-polymerized hexamethyldisiloxane coating on 3D printed substrates are non-cytotoxic and effective against respiratory pathogens.
Anna Machková, Eva Vaňková, Klára Obrová, Paola Fürhacker, Tereza Košutová, Thomas Lion

Front Microbiol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid and sustained T cell-based immunotherapy against invasive fungal disease via a combined two step procedure.
Sabine Tischer-Zimmermann, Elisabeth Salzer, Tamires Bitencourt, Nelli Frank, Christine Hoffmann-Freimüller, Thomas Lion

Front Immunol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal Shedding of SARS-CoV-2 in Children: No Evidence for Infectious Potential.
Filomena Nogueira, Klara Obrova, Meryl Haas, Evelyn Tucek, Karin Kosulin, Thomas Lion

Microorganisms· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study.
Helen E White, Matthew Salmon, Francesco Albano, Christina Søs Auður Andersen, Stefan Balabanov, Thomas Lion

Leukemia· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy.
Matthew Salmon, Helen E White, Hana Zizkova, Andrea Gottschalk, Eliska Motlova, Thomas Lion

Leukemia· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decontamination of High-Efficiency Mask Filters From Respiratory Pathogens Including SARS-CoV-2 by Non-thermal Plasma.
Klára Obrová, Eva Vaňková, Michal Sláma, Jan Hodek, Josef Khun, Thomas Lion

Front Bioeng Biotechnol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanopanel2 calls phased low-frequency variants in Nanopore panel sequencing data.
Niko Popitsch, Sandra Preuner, Thomas Lion

Bioinformatics· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asciminib and ponatinib exert synergistic anti-neoplastic effects on CML cells expressing -compound mutations.
Karoline V Gleixner, Yüksel Filik, Daniela Berger, Christina Schewzik, Gabriele Stefanzl, Thomas Lion

Am J Cancer Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of viremia during febrile neutropenic episodes in patients undergoing chemotherapy for malignant neoplasms.
Klára Obrová, Silke Grumaz, Marlene Remely, Stefan Czurda, Isabella Krickl, Thomas Lion

Am J Hematol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision Medicine in Hematology 2021: Definitions, Tools, Perspectives, and Open Questions.
Peter Valent, Alberto Orfao, Stefan Kubicek, Philipp Staber, Torsten Haferlach, Thomas Lion

Hemasphere· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Controlled Trial to Evaluate Safety and Efficacy of Expanded Recipient Regulatory T Cell Therapy and Tocilizumab Together With Donor Bone Marrow Infusion in HLA-Mismatched Living Donor Kidney Transplant Recipients (Trex001).
Rainer Oberbauer, Matthias Edinger, Gabriela Berlakovich, Peter Kalhs, Nina Worel, Thomas Lion

Front Med (Lausanne)· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis